BIONOR IMMUNO AS

Patent Applications and Registrations

Patent applications and USPTO patent grants for BIONOR IMMUNO AS.The latest application filed is for "dosage regimen for hiv vaccine".

Company Profile

6.20.22

BIONOR IMMUNO AS - Skien NO
Bionor Immuno As - Gulset Skien NO
Bionor Immuno AS - Gulset NO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides derived from viral proteins for use as immunogens and dosage reactants Grant 10,501,499 - Sorensen , et al. Dec	2019-12-10
Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent Grant 10,449,245 - Lundemose , et al. Oc	2019-10-22
Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer Grant 10,335,482 - Sorensen , et al.	2019-07-02
Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain Grant 10,251,949 - Gronvold , et al.	2019-04-09
Method for the vaccination against HIV Grant 10,143,737 - Lundemose , et al. De	2018-12-04
Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes Grant 10,124,059 - Lange , et al. November 13, 2	2018-11-13
Dosage Regimen For Hiv Vaccine App 20180140694 - Lundemose; Anker ; et al.	2018-05-24
Method For Reducing And/or Delaying Pathological Effects Of Human Immunodeficiency Virus I (hiv) Or For Reducing The Risk Of Developing Acquired Immunodeficiency Syndrome (aids) App 20170165321 - Lundemose; Anker ; et al.	2017-06-15
Peptide Scaffold Design App 20170112917 - Lange; Einar Tonnes ; et al.	2017-04-27
Dosage Regimen For Hiv Vaccine App 20170043009 - LUNDEMOSE; Anker ; et al.	2017-02-16
Peptide scaffold design Grant 9,550,811 - Lange , et al. January 24, 2	2017-01-24
Method For The Vaccination Against Hiv App 20170000876 - LUNDEMOSE; Anker ; et al.	2017-01-05
Dimeric Scaffold Peptides Comprising Hiv-1 Gp120 And Gp41 Epitopes App 20160375129 - Lange; Einar Tonnes ; et al.	2016-12-29
Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes Grant 9,493,514 - Lange , et al. November 15, 2	2016-11-15
Novel Therapeutic and Diagnostic Means App 20160144019 - GRONVOLD; Maja Sommerfelt ; et al.	2016-05-26
Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain Grant 9,200,065 - Gronvold , et al. December 1, 2	2015-12-01
Vaccine App 20150174235 - Hoie; Lars ; et al.	2015-06-25
Peptides Derived From Viral Proteins For Use As Immunogens And Dosage Reactants App 20150152140 - Sorensen; Birger ; et al.	2015-06-04
Hiv Vaccine App 20150132255 - Sorensen; Birger ; et al.	2015-05-14
Monomeric And Multimeric Immunogenic Peptides App 20140044746 - Lange; Einar Tonnes ; et al.	2014-02-13
Peptide Scaffold Design App 20130337002 - Lange; Einar Tonnes ; et al.	2013-12-19
Novel Therapeutic and Diagnostic Means App 20120263720 - Gronvold; Maja Sommerfelt ; et al.	2012-10-18
Method of producing an HIV-1 immune response Grant 7,709,004 - Sorensen May 4, 2	2010-05-04
Method of producing an HIV-1 immune response Grant 7,709,003 - Sorensen May 4, 2	2010-05-04
Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV Grant 7,612,168 - Sorensen November 3, 2	2009-11-03
HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit Grant 7,097,971 - Sorensen August 29, 2	2006-08-29
Modified HIV-1gag p17 peptide and immunogenic composition Grant 7,009,037 - Sorensen March 7, 2	2006-03-07
Method of producing an HIV-1 immune response App 20040259797 - Sorensen, Birger	2004-12-23
HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV Grant 6,706,859 - Sorensen March 16, 2	2004-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.